ArticleStroke and vascular neurology2026

Phase I dose-escalation study of tenecteplase, a third-generation fibrinolytic agent, combined with neuronavigation-assisted stereotactic minimally invasive puncture, in patients with acute spontaneous deep cerebral haemorrhage.

Zhiyou Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.